Lumen Technologies (LUMN) had the highest return between June 1, 2024 and August 23, 2024 by a mid-cap US stock, returning 386.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Lumen Technologies (LUMN) | 6/1/2024 - 8/23/2024 | 386.72% |
LandBridge Company LLC (LB) | 6/1/2024 - 8/23/2024 | 121.26% |
Verona Pharma PLC ADR (VRNA) | 6/1/2024 - 8/23/2024 | 113.67% |
GDS (GDS) | 6/1/2024 - 8/23/2024 | 106.05% |
ADMA Biologics (ADMA) | 6/1/2024 - 8/23/2024 | 90.87% |
Aurora Innovation (AUR) | 6/1/2024 - 8/23/2024 | 79.17% |
GeneDx (WGS) | 6/1/2024 - 8/23/2024 | 74.01% |
Clear Secure (YOU) | 6/1/2024 - 8/23/2024 | 69.69% |
Mirum Pharmaceuticals (MIRM) | 6/1/2024 - 8/23/2024 | 67.7% |
Upstart Holdings (UPST) | 6/1/2024 - 8/23/2024 | 64.84% |
Cellebrite DI (CLBT) | 6/1/2024 - 8/23/2024 | 61.18% |
Avidity Biosciences (RNA) | 6/1/2024 - 8/23/2024 | 60.77% |
Cinemark (CNK) | 6/1/2024 - 8/23/2024 | 60.6% |
Sezzle Inc Common Stock (SEZL) | 6/1/2024 - 8/23/2024 | 59.91% |
Bancorp (TBBK) | 6/1/2024 - 8/23/2024 | 56.75% |
Life360, Inc Common Stock (LIF) | 6/1/2024 - 8/23/2024 | 54.77% |
Trupanion (TRUP) | 6/1/2024 - 8/23/2024 | 52.04% |
ICU Medical (ICUI) | 6/1/2024 - 8/23/2024 | 52.03% |
Zeta Global (ZETA) | 6/1/2024 - 8/23/2024 | 51.27% |
Veracyte (VCYT) | 6/1/2024 - 8/23/2024 | 50.16% |
Genius Sports (GENI) | 6/1/2024 - 8/23/2024 | 48.96% |
Sprint Communications (S) | 6/1/2024 - 8/23/2024 | 48.85% |
TG Therapeutics (TGTX) | 6/1/2024 - 8/23/2024 | 48.06% |
Kymera Therapeutics (KYMR) | 6/1/2024 - 8/23/2024 | 47.06% |
Protagonist Therapeutics (PTGX) | 6/1/2024 - 8/23/2024 | 46.14% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
